Implanted Flexible Electronics Could Enhance Stem Cell Therapy for Diabetes: Study
USA: A team of scientists has developed a novel bioengineering platform that integrates flexible electronics into lab-grown pancreatic tissues, offering an unprecedented window into how insulin- and glucagon-producing cells mature.
Researchers have engineered pancreatic organoids by integrating flexible electronic devices into stem cell–derived islet cells. This innovation enables real-time monitoring of electrical activity, offering deeper insight into how these cells develop and function. The platform may help train and optimize lab-grown islet cells before transplantation, although its clinical application remains several years away.
The study, published in Science, was led by Qiang Li from the John A. Paulson School of Engineering and Applied Sciences at Harvard University. The research focuses on improving understanding of pancreatic islet biology, particularly the coordinated activity of alpha and beta cells, which regulate blood glucose through the secretion of glucagon and insulin.
Although stem cell–derived islets have emerged as a promising avenue for diabetes research and therapy, they often lack the functional maturity seen in natural human islets. Their ability to respond precisely to glucose fluctuations remains limited, posing a challenge for therapeutic applications. To address this gap, the researchers developed “cyborg” pancreatic organoids by embedding soft, stretchable electronic networks into developing three-dimensional tissues.
The following were the key points of the study:
- Implantable electronics enabled long-term, minimally invasive monitoring of electrical activity at the single-cell level within intact organoids.
- The system captured extracellular electrical signals over extended durations, allowing detailed functional analysis of individual cells.
- Researchers were able to distinguish alpha and beta cells based on their distinct electrical responses to glucose.
- Alpha cells showed increased electrical activity under low glucose conditions, consistent with glucagon secretion.
- Beta cells demonstrated higher activity at elevated glucose levels, aligning with insulin release.
- The platform enabled correlation of electrical activity with gene expression profiles, linking function to cellular identity.
- Both alpha and beta cells exhibited distinct baseline electrical states that evolved over time as the organoids matured.
- Improved hormone responsiveness was associated with increased and coordinated electrical activity across cell populations.
- Daily metabolic rhythms were found to influence synchronization of islet cell activity.
- Oscillations in electrical signaling followed circadian patterns, supporting coordinated hormone secretion.
- Findings highlight the importance of temporal regulation and cellular coordination in maintaining effective metabolic function.
- Beyond monitoring, the embedded electronics enabled targeted stimulation, where controlled electrical inputs enhanced glucose responsiveness in both alpha and beta cells, indicating the potential to actively direct their maturation.
Overall, this bioelectronic approach provides a powerful tool for studying human islet development in real time. It opens new avenues for refining stem cell–derived islets, with implications for disease modeling, drug testing, and regenerative therapies. While further work is needed before clinical translation, the findings mark a significant step toward engineering fully functional pancreatic tissues for diabetes treatment.
Reference:
Li, Q., Liu, R., Lin, Z., Zhang, X., Wang, W., Galicia-Silva, I. M., Liu, M., Gao, Z., Pollock, S. D., Alvarez-Dominguez, J. R., & Liu, J. (2026). Implanted flexible electronics reveal principles of human islet cell electrical maturation. Science. https://doi.org/aeb3295
Next Story